ABCG2 and melanoma: Resistance in melanoma BMs with BRAFV600 mutations is primarily mediated by drug efflux transporters, including P-glycoprotein (P-gp; ABCB1) and breast cancer resistance protein (BCRP; ABCG2), located at the BBB and impeding penetration into BMs [298].